Ophthalmologic Manifestations of Diphtheria
- Author: Andrew A Dahl, MD, FACS; Chief Editor: Hampton Roy, Sr, MD more...
The name diphtheria is derived from the Greek root for leather, which is descriptive for the pharyngeal membrane that characterizes the disease. Although its symptoms have been discussed by many authors of ancient and modern times, diphtheria has been known by its present name only since Bretonneau published a treatise in 1823. Hippocrates clinically described it, and, in the 20th century, diphtheria evolved from a major public health problem to a medical curiosity within the developed nations through the use of immunization measures.
Conjunctivitis diphtheritica has the property of exciting profuse exudation in the tissue of the conjunctivae, which has a great tendency to coagulate, leading to necrosis of the infiltrated tissue.
Diphtheria is an acute infectious disease caused by the gram-positive bacillus Corynebacterium diphtheriae. It is characterized by a primary lesion, usually within the respiratory tract, and more generalized symptoms caused by release and spread of bacterial exotoxins throughout the body. Diphtheria most commonly affects children younger than 10 years. Humans are the only known reservoir for C diphtheriae. The primary modes of spread are via airborne droplets or contact with respiratory secretions or exudates from infected skin lesions. Fortunately, the widespread immunization of infants using diphtheria toxoid has made this infection extremely rare in developed nations. Diphtheria was the leading cause of death in Canadian children aged 2-14 years only 75 years ago.
The primary pathological lesion of diphtheria is the development of a thick leathery membrane consisting of bacteria, dead cells from the mucous membranes, and fibrin. This membrane, surrounded by a narrow zone of inflammation, firmly adheres to the underlying tissues. Removal of this membrane reveals a bleeding edematous submucosal tissue. The membrane may be localized or extend widely, forming a cast of the pharynx and the tracheobronchial tree. Soft tissue edema of the airways can compromise respiratory function, and death by suffocation from soft tissue edema and aspiration of the membrane is common.
The major virulence of C diphtheriae results from the action of its potent exotoxin, a polypeptide chain produced at the site of the local lesion that passes into the bloodstream. The toxin, which inhibits protein synthesis in mammalian cells, affects all cells in the body but most prominently the heart, producing myocarditis; the kidney, resulting in renal tubular necrosis; and the nervous system, resulting in demyelination. Toxic demyelination occurs in 10% of all infected patients. The neuropathy usually occurs 2-6 weeks after infection, but it may be delayed for up to 3 months after primary infection.
At the turn of the century, in the United States, diphtheria was extremely common, occurring primarily in children, and it was one of the leading causes of death in infants and children. In the 1920s, when data were first gathered in the United States, there were approximately 150,000 cases and 13,000 deaths reported annually. After diphtheria immunization was introduced, the number of cases gradually fell to about 19,000 in 1945. When diphtheria immunization became widespread in the late 1940s, a more rapid decrease in the number of cases and deaths occurred.
From 1970-1979, an average of 196 cases per year were reported. Seventeen outbreaks of 15 or more cases occurred in the United States from 1959-1980, but there have been no outbreaks of multiple cases since 1980. From 1980-1989, the number of individual cases in the United States dropped to 24; 2 cases were fatal, and 18 occurred in persons aged 20 years or older. From 1990-2000, an additional 28 cases were reported, most having occurred in nonimmunized (or inadequately immunized) individuals, particularly those who travel to areas outside the United States where diphtheria is common and those who come into close contact with travelers from such areas.
Since 2000, 5 or fewer cases have been reported annually in the United States. Between 2004 and 2008, no cases of diphtheria were recorded in the United States.
The disease remains endemic in many parts of the third world, although decreases in incidence have occurred worldwide.
Epidemic diphtheria reemerged in the New Independent States (NIS) of the former Soviet Union, beginning in the Russian Federation in 1990 and affecting all 15 NIS by the end of 1994. Approximately 90% of all diphtheria cases reported worldwide during 1990-1995 were reported from the NIS. From 1990-1995, approximately 125,000 cases of diphtheria and 4000 deaths related to the disease were reported in the NIS.
At the time of the disintegration of the former Soviet Union in 1991, all NIS relied on supplies of vaccine and antitoxin from Russia, and most lacked the financial resources to procure them from the international market. Mass vaccination campaigns began in 1994, and they have been successful in controlling this epidemic.
In 2003, the World Health Organization reported 50 cases, including 3 in a resettlement camp for displaced persons in Kandahar. A mass vaccination campaign targeting the entire population of the camp (c. 40,000) was launched.
A diphtheria outbreak was reported in May 2010 in Haiti, in one of the settlements housing people displaced by the January 2010 Haitian earthquake. Prior to that, in October, 2009, another diphtheria outbreak in Haiti caused 11 cases and 5 deaths over a 4-week period.
A diphtheria outbreak of 98 cases occurred from February to November 2011 in northeastern Nigeria. There was a 21% fatality rate, primarily in young children. Low rates of immunization, delayed clinical recognition of diphtheria, and absence of treatment with antitoxin and appropriate antibiotics contributed to this epidemic and its severity.
The potent diphtheria exotoxin can cause myocarditis, renal tubular necrosis, or toxin demyelination of the central nervous system.
Children younger than 10 years more commonly are affected.
The epidemic in the New Independent States of the former Soviet Union in 1990-1995 was characterized by a high proportion of cases among adults.
Sloan FA, Berman S, Rosenbaum S, Chalk RA, Giffin RB. The fragility of the U.S. vaccine supply. N Engl J Med. 2004 Dec 2. 351(23):2443-7. [Medline].
Burkhard C, Choi M, Wilhelm H. [Optic neuritis as a complication in preventive tetanus-diphtheria-poliomyelitis vaccination: a case report]. Klin Monbl Augenheilkd. 2001 Jan. 218(1):51-4. [Medline].
Chandler JW, Milam DF. Diphtheria corneal ulcers. Arch Ophthalmol. 1978 Jan. 96(1):53-6. [Medline].
Coachman J. Diphtheric conjunctivitis. Mer J Ophth. 1951. 34:1176.
Dittmann S, Wharton M, Vitek C, et al. Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis. 2000 Feb. 181 Suppl 1:S10-22. [Medline].
Fuchs E. Textbook of Ophthalmology. 1889.
Hardy IR, Dittmann S, Sutter RW. Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet. 1996 Jun 22. 347(9017):1739-44. [Medline].
Pichichero ME, Rennels MB, Edwards KM, et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA. 2005 Jun 22. 293(24):3003-11. [Medline].
Rolleston JD. Diphtheric paralysis. Arch Pediatr. 1913. 30:335-45.
Rolleston JD, Ronaldson GW. Acute Infectious Diseases. 1940.
Tharmaphornpilas P, Yoocharoan P, Prempree P, Youngpairoj S, Sriprasert P, Vitek CR. Diphtheria in Thailand in the 1990s. J Infect Dis. 2001 Oct 15. 184(8):1035-40. [Medline].
Walshe FMR. On the pathogenesis of diphtheric paralysis. Q J Med. 1918-19. 12:14-37.